Tag Archives: rolapitant

Varubi (rolapitant) Approved for Chemotherapy-Induced Nausea and Vomiting

The US Food and Drug Administration (FDA) has approved Varubi (rolapitant) (Tesaro) as part of a combination of drugs to prevent nausea and vomiting caused by certain types of cancer chemotherapy. More specifically, it was approved to prevent delayed phase chemotherapy-induced nausea and vomiting (CINV). Continue reading